Complement C3 inhibitory peptide AMY-101 ameliorates brain injury in a mouse model of NMOSD
{{output}}
Background: Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory demyelinating disease of the central nervous system, clinically characterized primarily by optic neuritis and transverse myelitis. This stud... ...
